Login / Signup
Michel Burcklen
ORCID
Publication Activity (10 Years)
Years Active: 2021-2021
Publications (10 Years): 1
Top Topics
Double Blind
Phase Ii Study
Rectal Cancer
Top Venues
Clinical pharmacokinetics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Per Olsson Gisleskog
,
Belén Valenzuela
,
Tatiana Scherz
,
Michel Burcklen
,
Juan Jose Perez Ruixo
,
Italo Poggesi
An Exposure-Response Analysis of the Clinical Efficacy of Ponesimod in a Randomized Phase II Study in Patients with Multiple Sclerosis.
Clinical pharmacokinetics
60 (9) (2021)